- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-1-1-mer
- Ligands
- 4 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 33 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.5: 1 residues within 4Å:- Chain A: N.282
Ligand excluded by PLIPNAG.6: 2 residues within 4Å:- Chain A: N.331, Q.580
Ligand excluded by PLIPNAG.7: 3 residues within 4Å:- Chain A: N.343, S.371, A.372
Ligand excluded by PLIPNAG.8: 1 residues within 4Å:- Chain A: N.603
Ligand excluded by PLIPNAG.9: 1 residues within 4Å:- Chain A: N.616
Ligand excluded by PLIPNAG.10: 1 residues within 4Å:- Chain A: N.657
Ligand excluded by PLIPNAG.11: 2 residues within 4Å:- Chain A: N.709, G.1131
Ligand excluded by PLIPNAG.12: 1 residues within 4Å:- Chain A: N.801
Ligand excluded by PLIPNAG.13: 2 residues within 4Å:- Chain A: A.706, N.1074
Ligand excluded by PLIPNAG.14: 1 residues within 4Å:- Chain A: N.1098
Ligand excluded by PLIPNAG.15: 1 residues within 4Å:- Chain A: N.61
Ligand excluded by PLIPNAG.16: 1 residues within 4Å:- Chain B: N.61
Ligand excluded by PLIPNAG.17: 2 residues within 4Å:- Chain B: E.281, N.282
Ligand excluded by PLIPNAG.18: 3 residues within 4Å:- Chain B: N.343, S.371, A.372
Ligand excluded by PLIPNAG.19: 1 residues within 4Å:- Chain B: N.603
Ligand excluded by PLIPNAG.20: 1 residues within 4Å:- Chain B: N.657
Ligand excluded by PLIPNAG.21: 1 residues within 4Å:- Chain B: N.709
Ligand excluded by PLIPNAG.22: 1 residues within 4Å:- Chain B: N.717
Ligand excluded by PLIPNAG.23: 1 residues within 4Å:- Chain B: N.801
Ligand excluded by PLIPNAG.24: 1 residues within 4Å:- Chain B: N.1074
Ligand excluded by PLIPNAG.25: 2 residues within 4Å:- Chain B: N.1098, H.1101
Ligand excluded by PLIPNAG.26: 3 residues within 4Å:- Chain C: P.26, Y.28, N.61
Ligand excluded by PLIPNAG.27: 1 residues within 4Å:- Chain C: N.165
Ligand excluded by PLIPNAG.28: 1 residues within 4Å:- Chain C: N.282
Ligand excluded by PLIPNAG.29: 2 residues within 4Å:- Chain C: N.331, Q.580
Ligand excluded by PLIPNAG.30: 1 residues within 4Å:- Chain C: N.603
Ligand excluded by PLIPNAG.31: 1 residues within 4Å:- Chain C: N.616
Ligand excluded by PLIPNAG.32: 1 residues within 4Å:- Chain C: N.657
Ligand excluded by PLIPNAG.33: 1 residues within 4Å:- Chain C: N.709
Ligand excluded by PLIPNAG.34: 1 residues within 4Å:- Chain C: N.801
Ligand excluded by PLIPNAG.35: 1 residues within 4Å:- Chain C: N.1074
Ligand excluded by PLIPNAG.36: 1 residues within 4Å:- Chain C: N.1098
Ligand excluded by PLIPNAG.37: 1 residues within 4Å:- Chain C: N.1134
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Rapp, M. et al., Modular basis for potent SARS-CoV-2 neutralization by a prevalent VH1-2-derived antibody class. Cell Rep (2021)
- Release Date
- 2021-04-14
- Peptides
- Spike glycoprotein: ABC
Fab H4 variable domain heavy chain: D
Fab H4 variable domain light chain: E - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
HE
L
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-1-1-mer
- Ligands
- 4 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 33 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Rapp, M. et al., Modular basis for potent SARS-CoV-2 neutralization by a prevalent VH1-2-derived antibody class. Cell Rep (2021)
- Release Date
- 2021-04-14
- Peptides
- Spike glycoprotein: ABC
Fab H4 variable domain heavy chain: D
Fab H4 variable domain light chain: E - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
HE
L